The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis
Leukemia & Lymphoma | April 11, 2024 | Volume: 65 | Issue: 8 | Pages: 1068-1078
10.1080/10428194.2024.2337803
| PMID 38600883